BGG492 (selurampanel), an AMPA/kainate receptor antagonist drug for epilepsy

Author: Faught Edward  

Publisher: Informa Healthcare

ISSN: 1354-3784

Source: Expert Opinion on Investigational Drugs, Vol.23, Iss.1, 2014-01, pp. : 107-113

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content